Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...

Jiawan, D., Bansie, R., Chan, M., Thakoer, I. and Gopie, F.A. (2025) Necrotizing Sarcoid Granulomatosis with Concurrent ...

Malti Chahar and Tanya Mittal face the final ration task handcuffed together, risking zero food for the house.

Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have ...

Most cancer deaths occur in organs without routine screening tests available. GRAIL's Galleri blood test aims to find these ...

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying.

A new blood test may help catch cancer much earlier. Researchers say it could one day make routine screening far more ...

Scientists led by Stephanie Eisenbarth, MD, Ph.D., the Roy and Elaine Patterson Professor of Medicine and director of the ...

Globally, metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease, affecting up to one in three people in the general population, with an ...

Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...